Yvonne C. W. Yau

Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report.

Sputum induction in routine clinical care of children with cystic fibrosis.

Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions.

Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.

Nosocomial transmission of group B streptococci proven by positive environmental culture.

Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients.

Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.

Lung microbiota across age and disease stage in cystic fibrosis.

Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis.

Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.

Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.

Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients.

Navigating social and ethical challenges of biobanking for human microbiome research.

Early-Onset Invasive Candidiasis in Extremely Low Birth Weight Infants: Perinatal Acquisition Predicts Poor Outcome.

MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.

Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population.

Burkholderia multivorans septicemia in a pediatric liver transplant patient.

A genome-wide association analysis reveals a potential role for recombination in the evolution of antimicrobial resistance in Burkholderia multivorans.

Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams.

Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations.

Clinical Outcomes Associated with Complex Infection in Patients with Cystic Fibrosis.

Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways.